COMMUNIQUÉS West-GlobeNewswire

Avalon GloboCare Announces Plans to Accelerate Commercialization of Proprietary CAR-T Technologies through Launch of Wholly Owned Subsidiary - Avactis Biosciences
18/07/2018
FREEHOLD, N.J., July 18, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies and therapeutics, announced today that the Company has formed a new wholly [...]
Adaptimmune Announces Favorable Review of Safety from One Billion Cell Dose Cohort in MAGE-A10 SPEAR T-cell Study and Initiation of Third Dosing Cohorts
18/07/2018
PHILADELPHIA and OXFORD, United Kingdom, July 18, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced favorable review of safety data from the [...]
Myriad Announces Coverage Decision by Kroger® Prescription Plans for Vectra DA®
18/07/2018
SALT LAKE CITY, July 18, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a worldwide leader in personalized medicine, today announced that Kroger Prescription Plans, will provide Vectra ® DA as a benefit [...]
Akers Biosciences Signs a Further Independent Sales Representative Organization for Heparin PF4 Rapid Test Covering Additional 12 States
18/07/2018
THOROFARE, N.J.,, July 18, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces another agreement [...]
Evogene Financial Results for the Second Quarter of 2018
18/07/2018
Earnings Announcement Schedule REHOVOT, Israel, July 18, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets, announced [...]
Catalyst Biosciences Announces Positive Interim Data from a Phase 2/3 Study of Marzeptacog Alfa (Activated) in Individuals with Hemophilia A or B with Inhibitors
18/07/2018
Interim data support goal of significantly reducing annualized bleed rates with daily subcutaneous injections of marzeptacog alfa (activated) Conference call and webcast to be held today, July 18, 2018 at 8:30 a.m. EDT [...]
Emblem Announces $3 Million Strategic Equity Investment in Natura Naturals and 9,000 kg Supply Agreement over three years
18/07/2018
TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV:EMC) (TSXV:EMC.WT) (OTCBB:EMMBF) (“Emblem” or the “Company”), announced today that it is making a strategic equity investment (the “Equity Investment”) into [...]
Orion Group Half-Year Financial Report January-June 2018
18/07/2018
ORION CORPORATION HALF-YEAR FINANCIAL REPORT JANUARY-JUNE 2018 18 JULY 2018 at 12:00 EEST Orion Group Half-Year Financial Report January-June 2018 Orion's net sales for continuing operations in January-June 2018 [...]
Orion Corporation's financial reporting and Annual General Meeting in 2019
18/07/2018
ORION CORPORATION STOCK EXCHANGE RELEASE 18 JULY 2018 at 11.00 EEST Orion Corporation's financial reporting and Annual General Meeting in 2019 Orion Corporation will publish its Financial Statement Release 2018 on [...]
Esperite N.V. (ESP) : Additional delays needed on the publication of the Annual Report 2017
18/07/2018
Amsterdam, The Netherlands - 18 July 2018 Following earlier information provided regarding the delay on the publication of the Annual Report 2017 mainly due to technical issues which have now been identified, Esperite [...]
Novartis delivers solid growth in second quarter and continues transformation to a focused medicines company
18/07/2018
Net sales grew 5% (cc[1], +7% USD) mainly driven by: Cosentyx grew to USD 701 million, (+40% cc) with strong growth in all indications in the US and EU Entresto sales more than doubled to USD 239 million, (+113% cc) [...]
Novartis réalise une solide croissance au deuxième trimestre et poursuit sa transformation en une entreprise axée sur les médicaments
18/07/2018
Hausse du chiffre d'affaires net de 5% (tcc[1], +7% USD), stimulée principalement par: Cosentyx, qui a progressé à USD 701 millions, (+40% tcc), enregistrant une forte croissance dans toutes ses indications aux Etats- [...]
Rubius Therapeutics Announces Pricing of Initial Public Offering
18/07/2018
CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced the [...]
Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering
18/07/2018
SAN DIEGO, July 17, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Kane Biotech Announces Closing of Loan Transaction
18/07/2018
WINNIPEG, Manitoba, July 17, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) today announced that it has received a loan (the “Loan”) in the amount of $500,000 [...]
Actinium Forms Nuclear Medicine Focused Advisory Board to Facilitate Pipeline Clinical Development and Iomab-B Commercial Planning
17/07/2018
NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN:ATNM) ("Actinium" or "the Company"), today announced that it has appointed the members of its Nuclear Medicine Clinical Advisory [...]
CorVel Announces Quarterly Earnings Release Webcast
17/07/2018
IRVINE, Calif., July 17, 2018 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast Hosts: Gordon Clemons, Chief Executive Officer Michael Combs, President Date: Tuesday, July 31 st , 2018 Time: 11:30 am EST. [...]
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 28, 2018
17/07/2018
LYON, France and CAMBRIDGE, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext:ERYP) (Nasdaq:ERYP) announced that its 2018 Annual General Meeting was held in Lyon on Thursday, June 28, 2018. At the [...]
Imagin Medical Reports Research Study Progress
17/07/2018
VANCOUVER, British Columbia and BOSTON, July 17, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) announced today favorable results in the 10- [...]

Pages